Management of Gram-Positive Cocci in 1 of 1 Blood Culture Bottle in a 16-Month-Old
This single positive blood culture with gram-positive cocci most likely represents contamination with skin flora (coagulase-negative staphylococci or viridans streptococci), but you must treat empirically for true bacteremia with Staphylococcus aureus until proven otherwise, using ampicillin plus gentamicin as the standard regimen for this age group. 1, 2
Understanding the Clinical Context
The critical issue here is distinguishing contamination from true bacteremia:
- Blood cultures contaminated with skin flora during collection are common, and contamination rates should not exceed 3% 1
- Common blood culture contaminants include coagulase-negative staphylococci, viridans group streptococci, diphtheroids, and Bacillus species 1
- However, only 1 of 1 bottle being positive is problematic - IDSA/ASM guidelines recommend obtaining 1-2 aerobic bottles for children, making interpretation difficult when only a single bottle was drawn 1
- For a 16-month-old child (typically 10-12 kg), the recommended blood culture volume is 4-6 mL total, which should ideally be split between 2 bottles if sufficient volume is available 1
Immediate Diagnostic Steps
You must obtain additional blood cultures immediately before starting antibiotics:
- Draw at least one additional blood culture set by peripheral venipuncture (not from a catheter, which has higher contamination risk) 1
- Catheter-drawn blood cultures have significantly higher risk of false positives 1
- If the child has a central venous catheter, consider catheter-associated bloodstream infection in your differential 1
Gram Stain Morphology Interpretation
The appearance of gram-positive cocci on direct Gram stain provides important clues:
- Gram-positive cocci in clusters are 98% sensitive and 100% specific for Staphylococcus species (including S. aureus) or Peptococcus 3
- Gram-positive cocci in chains or pairs are 100% sensitive and 98% specific for Streptococcus species 3
- This distinction is highly reliable and should guide your initial antimicrobial selection 3
Empirical Antibiotic Management
Start empirical therapy immediately while awaiting culture identification:
If Gram Stain Shows Clusters (Likely Staphylococcus):
- Ampicillin 200 mg/kg/day IV divided every 6 hours PLUS gentamicin 7.5 mg/kg/day IV divided every 8 hours 2
- This combination is the FDA-approved regimen for neonatal sepsis and serious staphylococcal infections in young children 2
- Gentamicin is effective against both coagulase-positive and coagulase-negative Staphylococcus species 2
- In the neonate and young infant with suspected bacterial sepsis or staphylococcal pneumonia, a penicillin-type drug is indicated as concomitant therapy with gentamicin 2
If Gram Stain Shows Chains/Pairs (Likely Streptococcus):
- Ampicillin 200 mg/kg/day IV divided every 6 hours is appropriate first-line therapy 1
- Consider adding gentamicin if endocarditis is suspected (see below) 1
Clinical Scenarios Requiring Broader Coverage:
- If community-acquired MRSA is suspected based on clinical presentation (severe pneumonia, skin/soft tissue infection), add vancomycin 15 mg/kg IV every 6 hours 4
- If the child appears toxic or has severe sepsis, do not delay antibiotics while awaiting additional cultures 1, 4
Assessing for Serious Complications
You must evaluate for endocarditis and other metastatic infections:
- Obtain echocardiography if S. aureus bacteremia is confirmed, as this is a major criterion for infective endocarditis by modified Duke criteria 1, 5
- The modified Duke criteria have been validated for diagnosing IE in children, though with some limitations in the setting of central venous catheters 1
- S. aureus bacteremia qualifies as a major microbiological criterion for endocarditis, regardless of whether infection was nosocomial or community-acquired 1
- Consider removing any central venous catheter, as attempting to salvage it may prolong bacteremia and confound the diagnosis 1
Clinical Monitoring and Re-evaluation
Establish a structured monitoring plan:
- Re-evaluate the child within 48-72 hours to assess clinical response 4
- If the child remains febrile or unwell 48 hours after starting antibiotics, re-evaluation is necessary with consideration of complications 1
- Repeat blood cultures daily until sterile to assess treatment adequacy 5
- Monitor oxygen saturation and maintain >92% with supplemental oxygen if needed 1, 4
Treatment Modification Based on Final Culture Results
Adjust therapy once organism identification and susceptibilities are available:
If Coagulase-Negative Staphylococci (Likely Contaminant):
- If the child is clinically well, repeat blood cultures are negative, and there is no evidence of catheter-associated infection, discontinue antibiotics 1
- Laboratories should have policies for abbreviated work-up of common contaminants, including absence of susceptibility testing 1
If Methicillin-Susceptible S. aureus (MSSA):
- Switch to an anti-staphylococcal beta-lactam such as nafcillin, oxacillin, or cefazolin 5
- Duration: 2 weeks for uncomplicated bacteremia, 4-6 weeks for complicated bacteremia (endocarditis, metastatic infection) 5
If Methicillin-Resistant S. aureus (MRSA):
- Continue vancomycin with appropriate dosing to achieve trough levels of 15-20 mg/L 5
- Monitor vancomycin trough levels closely 5
If Streptococcus pneumoniae or Viridans Streptococci:
- Continue ampicillin if susceptible 1
- Note that S. pneumoniae and other gram-positive organisms may grow best in anaerobic bottles 1
Common Pitfalls to Avoid
Critical errors that compromise patient outcomes:
- Never dismiss a single positive blood culture without clinical correlation - while likely contamination, true bacteremia can present this way, especially with inadequate blood culture volumes 1
- Do not delay antibiotics in a toxic-appearing child while awaiting additional cultures 1, 4
- Avoid using chlorhexidine for skin disinfection in children <2 months old - use povidone-iodine followed by alcohol instead 1
- Do not assume penicillin resistance mechanisms - adding a beta-lactamase inhibitor is inappropriate for penicillin-resistant pneumococci, which have altered penicillin-binding proteins 6
- Never refrigerate blood prior to incubation - this can reduce organism recovery 1
Special Considerations for This Age Group
Age-specific factors affecting management:
- For children aged 2.1-12.7 kg (which includes most 16-month-olds), the recommended total blood culture volume is 6 mL split between 2 bottles when possible 1
- When 10 mL of blood or less is collected, it should be inoculated into a single aerobic blood culture bottle 1
- Young children presenting with mild symptoms of lower respiratory tract infection need not be treated with antibiotics, but bacteremia changes this calculus entirely 1